Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386562363> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W4386562363 endingPage "ii58" @default.
- W4386562363 startingPage "ii58" @default.
- W4386562363 abstract "Abstract BACKGROUND Withdrawal of antiseizure medication treatment (ASM) can be considered after completion of antitumour treatment in glioma patients who no longer suffer from seizures. We compared the risk of recurrent seizures after ASM withdrawal between patients with short-term, medium-term versus long-term seizure freedom after antitumour treatment. MATERIAL AND METHODS In this retrospective observational study, the primary outcome was time to recurrent seizure, from the starting date of no ASM treatment up to 36 months follow-up. Cox proportional hazards models were used to study the effect of risk factors on time to recurrent seizure. Stratification was done with information known at baseline. Short-term seizure freedom was defined as ≥3 months, but <12 months; medium-term as 12-24 months; and long-term as ≥24 months seizure freedom from the date of last antitumour treatment. RESULTS This study comprised of 109 patients; 31% (34/109) were in the short-term, 29% (32/109) in the medium-term, and 39% (43/109) in the long-term group. A recurrent seizure was experienced by 44% (15/34) of the patients in the short-term, 31% (10/32) in the medium-term, and 44% (19/43) in the long-term group. Seizure recurrence risk was similar between patients in the short-term group as compared to the medium-term (cause-specific adjusted hazard ratio [aHR]=0.65 [95%CI=0.29-1.46]) and long-term group (cause-specific aHR=1.04 [95%CI=0.52-2.09]). CONCLUSION Seizure recurrence risk is relatively similar between patients with short-term, medium-term, and long-term seizure freedom after completion of antitumour treatment." @default.
- W4386562363 created "2023-09-10" @default.
- W4386562363 creator A5004901028 @default.
- W4386562363 creator A5006474472 @default.
- W4386562363 creator A5018771146 @default.
- W4386562363 creator A5027431274 @default.
- W4386562363 creator A5037395192 @default.
- W4386562363 creator A5038273452 @default.
- W4386562363 creator A5056837393 @default.
- W4386562363 creator A5066947589 @default.
- W4386562363 creator A5085953690 @default.
- W4386562363 date "2023-09-01" @default.
- W4386562363 modified "2023-10-16" @default.
- W4386562363 title "P09.01.A IMPACT OF TIMING OF ANTISEIZURE MEDICATION WITHDRAWAL ON SEIZURE RECURRENCE IN GLIOMA PATIENTS: A RETROSPECTIVE OBSERVATIONAL STUDY" @default.
- W4386562363 doi "https://doi.org/10.1093/neuonc/noad137.187" @default.
- W4386562363 hasPublicationYear "2023" @default.
- W4386562363 type Work @default.
- W4386562363 citedByCount "0" @default.
- W4386562363 crossrefType "journal-article" @default.
- W4386562363 hasAuthorship W4386562363A5004901028 @default.
- W4386562363 hasAuthorship W4386562363A5006474472 @default.
- W4386562363 hasAuthorship W4386562363A5018771146 @default.
- W4386562363 hasAuthorship W4386562363A5027431274 @default.
- W4386562363 hasAuthorship W4386562363A5037395192 @default.
- W4386562363 hasAuthorship W4386562363A5038273452 @default.
- W4386562363 hasAuthorship W4386562363A5056837393 @default.
- W4386562363 hasAuthorship W4386562363A5066947589 @default.
- W4386562363 hasAuthorship W4386562363A5085953690 @default.
- W4386562363 hasConcept C118552586 @default.
- W4386562363 hasConcept C126322002 @default.
- W4386562363 hasConcept C167135981 @default.
- W4386562363 hasConcept C187212893 @default.
- W4386562363 hasConcept C207103383 @default.
- W4386562363 hasConcept C23131810 @default.
- W4386562363 hasConcept C2778186239 @default.
- W4386562363 hasConcept C44249647 @default.
- W4386562363 hasConcept C50382708 @default.
- W4386562363 hasConcept C71924100 @default.
- W4386562363 hasConceptScore W4386562363C118552586 @default.
- W4386562363 hasConceptScore W4386562363C126322002 @default.
- W4386562363 hasConceptScore W4386562363C167135981 @default.
- W4386562363 hasConceptScore W4386562363C187212893 @default.
- W4386562363 hasConceptScore W4386562363C207103383 @default.
- W4386562363 hasConceptScore W4386562363C23131810 @default.
- W4386562363 hasConceptScore W4386562363C2778186239 @default.
- W4386562363 hasConceptScore W4386562363C44249647 @default.
- W4386562363 hasConceptScore W4386562363C50382708 @default.
- W4386562363 hasConceptScore W4386562363C71924100 @default.
- W4386562363 hasIssue "Supplement_2" @default.
- W4386562363 hasLocation W43865623631 @default.
- W4386562363 hasOpenAccess W4386562363 @default.
- W4386562363 hasPrimaryLocation W43865623631 @default.
- W4386562363 hasRelatedWork W1997539222 @default.
- W4386562363 hasRelatedWork W2010946518 @default.
- W4386562363 hasRelatedWork W2587836152 @default.
- W4386562363 hasRelatedWork W2765980456 @default.
- W4386562363 hasRelatedWork W2976382042 @default.
- W4386562363 hasRelatedWork W3187162536 @default.
- W4386562363 hasRelatedWork W4297458902 @default.
- W4386562363 hasRelatedWork W4323364654 @default.
- W4386562363 hasRelatedWork W4366529679 @default.
- W4386562363 hasRelatedWork W4384497977 @default.
- W4386562363 hasVolume "25" @default.
- W4386562363 isParatext "false" @default.
- W4386562363 isRetracted "false" @default.
- W4386562363 workType "article" @default.